Traditional biomarkers may not be sensitive or specific enough to detect early or low-level exposures to toxicants. Novel biomarkers offer more precise, early, and sensitive detection of toxic effects, thereby improving risk assessment and management. They can provide insights into the mechanisms of toxicity at a molecular level, facilitating the development of targeted therapies and preventive measures.
